2 assets in Hereditary Hemophagocytic Lymphohistiocytosis

Therapeutic assets addressing Hereditary Hemophagocytic Lymphohistiocytosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Icaspase9-Transduced T Cells Hereditary Hemophagocytic Lymphohistiocytosis	Baylor College of Medicine	P1	CC (43)
Rimiducid Hereditary Hemophagocytic Lymphohistiocytosis	Baylor College of Medicine	P1	CC (43)